Ascentage Pharma will be conducting a multicenter, open-label Phase I study designed to evaluate the safety, tolerability, ...
Hershey ( HSY) anticipates a meaningful increase in profits for FY26, as higher prices and the proliferation of weight loss ...
OVATION 3 is IMUNON’s pivotal Phase 3 study of IMMN-001, an IL-12 gene-mediated immunotherapy, in women with advanced stage epithelial ovarian cancer. The study is supported with unprecedented overall ...
SOL-1 Phase 3 superiority trial results remain masked to dateSOL-1 data expected to be presented at the 49th Macula Society Annual Meeting Ocular ...
1) the active drug substance Axitinib, which used to belong to Pfizer, is an FDA-approved, oral, potent VEGFR inhibitor. So ...
In this week's It’s Debatable article, Rosen and Moster debate if President Trump's foreign policy actions have increased the ...
A groundbreaking phase 2 trial explores a novel, chemotherapy-free immunotherapy for relapsed indolent B-cell lymphomas, aiming to enhance patient outcomes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results